three
unpreced
outbreak
emerg
human
coronaviru
hcov
infect
begin
twentyfirst
centuri
highlight
necess
readili
avail
accur
fast
diagnost
test
method
laboratori
diagnost
method
human
coronaviru
infect
evolv
substanti
develop
novel
assay
well
avail
updat
test
emerg
one
newer
laboratori
method
fast
highli
sensit
specif
gradual
replac
convent
gold
standard
present
review
current
laboratori
method
avail
test
coronavirus
focus
coronaviru
diseas
outbreak
go
wuhan
viral
pneumonia
typic
result
product
purul
sputum
thu
nasopharyng
swab
usual
collect
method
use
obtain
specimen
test
nasopharyng
specimen
may
miss
infect
deeper
specimen
may
need
obtain
bronchoscopi
altern
repeat
test
use
time
likelihood
present
nasopharynx
increas
sever
integr
randomaccess
pointofcar
molecular
devic
current
develop
fast
accur
diagnosi
infect
assay
simpl
fast
safe
use
local
hospit
clinic
bear
burden
identifi
treat
patient
cov
merscov
temper
region
endem
hcov
usual
display
winter
season
although
detect
sporad
throughout
year
endem
hcov
global
distribut
maintain
human
popul
sarscov
pandem
came
end
http
wwwwhointcsrresourc
access
februari
less
year
first
report
case
contrast
human
case
caus
merscov
continu
report
time
write
seven
year
first
report
case
laboratoryconfirm
mer
case
occur
eastern
mediterranean
region
major
saudi
arabia
unlik
endem
hcov
sarscov
merscov
maintain
zoonot
reservoir
sar
mer
outbreak
driven
part
superspread
event
individu
directli
infect
disproport
larg
number
contact
coronaviru
diseas
covid
epidem
origin
wuhan
china
market
sold
exot
anim
consumpt
base
genet
related
betacoronavirus
like
zoonot
reservoir
howev
precis
sourc
initi
infect
human
remain
confirm
appear
substanti
contagi
sarscov
tabl
distribut
differ
mammalian
speci
unknown
interest
question
suscept
farm
anim
pet
role
epidemiolog
cycl
angiotensinconvert
enzym
receptor
share
similar
human
infect
caus
endem
hcov
incub
period
day
associ
mild
upper
respiratori
symptom
common
cold
endem
hcov
among
frequent
caus
upper
respiratori
tract
infect
lower
respiratori
tract
infect
bronchiol
pneumonia
rare
follow
incub
period
usual
day
patient
infect
sarscov
often
present
symptom
fever
headach
myalgia
respiratori
symptom
includ
cough
dyspnoea
usual
develop
sever
day
week
ill
onset
atyp
pneumonia
respiratori
deterior
occur
case
incub
period
clinic
cours
mer
similar
sar
except
higher
proport
case
progress
respiratori
deterior
distress
incub
period
clinic
cours
infect
probabl
similar
sar
li
et
al
first
report
mean
incub
period
day
fever
cough
frequent
report
earli
cours
ill
infect
also
character
dyspnoea
respiratori
distress
posit
chest
xray
lower
respiratori
symptom
often
develop
week
onset
initi
symptom
global
case
death
due
sarscov
report
casefat
ratio
approxim
http
wwwwhointcsrsarsen
whoconsensuspdf
access
februari
septemb
novemb
laboratoryconfirm
case
mer
death
http
wwwwhointemergenciesmerscoven
access
februari
mer
casefat
rate
tripl
sar
person
year
age
group
highest
risk
primari
case
short
time
emerg
decemb
march
report
countri
time
write
situat
evolv
rapidli
confirm
case
report
global
china
death
china
casefat
rate
death
outsid
china
countri
contin
outsid
china
south
korea
iran
europ
particularli
itali
experienc
high
number
case
http
wwwwhointemergenciesdiseasesnovelcoro
access
march
mortal
rate
vari
wide
depend
age
patient
underli
risk
factor
denomin
definitionhospit
case
symptomat
case
moder
sever
case
etc
studi
adult
patient
mean
age
chronic
ill
pneumonia
admit
intens
care
unit
icu
die
within
day
contrast
studi
hospit
patient
median
age
year
across
beij
show
case
sever
mild
fatal
rate
mortal
highest
older
person
median
age
year
treatment
sever
hcov
infect
support
although
random
doubleblind
control
clinic
trial
conduct
gilead
drug
remdesivir
base
one
studi
focus
children
total
children
age
month
year
report
china
paediatr
case
laboratoryconfirm
infect
mild
case
death
report
first
month
current
outbreak
spread
rapidli
throughout
china
caus
vari
degre
ill
death
rate
patient
often
present
without
fever
mani
abnorm
radiolog
find
chines
center
diseas
control
prevent
team
analys
patient
record
laboratoryconfirm
case
suspect
case
clinic
diagnos
case
asymptomat
case
confirm
case
ill
sever
includ
pneumonia
short
breath
critic
diseas
mark
respiratori
failur
septic
shock
multiorgan
failur
overal
casefat
rate
death
includ
studi
major
peopl
age
older
underli
medic
condit
http
wwwcidrapumnedunewsperspect
access
februari
must
appreci
matter
accur
fast
laboratori
test
method
diagnosi
viral
pneumonia
caus
involv
collect
correct
specimen
patient
right
time
endem
hcov
detect
varieti
upper
lower
respiratori
sourc
includ
throat
nasal
nasopharyng
np
sputum
bronchial
fluid
wang
et
al
report
oropharyng
op
swab
n
use
much
frequent
np
swab
n
china
outbreak
howev
rna
detect
op
swab
significantli
lower
np
swab
us
center
diseas
control
prevent
cdc
recommend
collect
upper
respiratori
np
swab
collect
op
specimen
lower
prioriti
collect
combin
tube
np
swab
http
wwwcdcgovcoronaviru
access
march
swab
specimen
place
univers
viral
transport
medium
nasopharyng
aspir
also
suitabl
specimen
detect
hcov
sensit
detect
sarscov
merscov
collect
test
upper
lower
respiratori
sampl
sputum
bronchoalveolar
lavag
fluid
bal
recommend
howev
collect
sputum
particularli
bal
via
bronchoscopi
increas
biosafeti
risk
healthcar
worker
creation
aerosol
droplet
proper
use
person
protect
equip
ppe
healthcar
worker
import
bronchoscopi
highli
technic
procedur
requir
welltrain
staff
may
avail
mani
part
world
upper
respiratori
specimen
easi
collect
therebi
increas
access
test
patient
mild
symptom
resourc
limit
set
sarscov
merscov
rna
also
detect
stool
urin
blood
specimen
although
gener
less
reliabl
respiratori
specimen
except
sarscov
rna
consist
detect
fece
two
week
symptom
onset
sensit
detect
endem
hcov
upper
respiratori
specimen
collect
within
first
day
symptom
onset
dynam
rna
shed
mer
sar
patient
may
reflect
specimen
sourc
sever
ill
well
underli
risk
factor
among
hospit
patient
requir
ventil
support
merscov
rna
level
upper
respiratori
tract
usual
peak
first
week
symptom
onset
among
eventu
fatal
case
requir
ventil
rna
level
lower
respiratori
tract
specimen
peak
week
similar
shed
pattern
seen
sarscov
rna
posit
rate
peak
upper
respiratori
tract
specimen
day
symptom
onset
steadili
declin
rna
posit
rate
lower
respiratori
tract
specimen
remain
higher
throughout
week
onset
ill
one
studi
diabet
associ
prolong
merscov
rna
shed
respiratori
tract
viral
pneumonia
typic
result
product
purul
sputum
thu
nasopharyng
swabwash
usual
collect
method
use
obtain
specimen
test
nasopharyng
specimen
may
miss
earli
infect
deeper
specimen
may
need
obtain
bronchoscopi
altern
repeat
test
use
time
likelihood
present
nasopharynx
increas
selfcollect
saliva
specimen
test
posit
patient
suggest
promis
noninvas
specimen
diagnosi
monitor
infect
control
infect
time
write
littl
data
perform
upper
vs
lower
respiratori
tract
specimen
detect
serum
anoth
sourc
detect
howev
patient
hospit
pneumonia
detect
rna
serum
specimen
collect
laboratori
test
hcov
maintain
refriger
temperatur
h
frozen
http
wwwcdcgovcoronaviru
access
march
rectal
specimen
report
posit
patient
infect
patient
travel
exposur
histori
symptom
suggest
possibl
infect
highrisk
novel
agent
sarscov
merscov
initi
handl
specimen
perform
biosafeti
level
condit
specimen
aliquot
render
noninfecti
lysi
anoth
method
viru
isol
routin
perform
situat
http
wwwasmorg
articlespolicylaboratoryresponsenetworklrnsentinellevelc
access
februari
us
cdc
biosafeti
guidelin
state
routin
diagnost
test
specimen
suspect
confirm
patient
handl
laboratori
use
standard
precaut
http
wwwcdc
access
march
isol
hcov
cell
cultur
routin
perform
diagnost
purpos
due
lack
permiss
cell
line
time
result
labour
expertis
requir
lack
commerci
antisera
cultur
confirm
tabl
sarscov
merscov
grow
primari
monkey
cell
cell
line
vero
cell
cultur
perform
suspect
case
routin
diagnost
laboratori
biosafeti
reason
howev
viru
isol
cell
cultur
critic
obtain
isol
character
support
develop
vaccin
therapeut
agent
rapid
antigen
test
would
theoret
provid
advantag
fast
time
result
lowcost
detect
hcov
like
suffer
poor
sensit
base
experi
method
influenza
flu
virus
tabl
prepeer
review
articl
diao
et
al
report
fluoresc
immunochromatograph
assay
accur
rapid
earli
simpl
method
detect
nucleocapsid
protein
np
swab
diagnosi
http
access
march
incorpor
colloid
goldlabel
immunoglobulin
g
igg
detect
reagent
approach
may
increas
sensit
rapid
antigen
test
respiratori
virus
monoclon
antibodi
specif
prepar
novel
approach
concentr
antigen
amplifi
detect
phase
need
method
clinic
util
sona
nanotech
halifax
canada
develop
quickrespons
lateralflow
test
screen
patient
target
produc
result
min
http
sonananocomsonadevelopsrapidscreeningtestforcoronaviru
access
februari
time
specimen
collect
viral
titr
highest
may
improv
diagnost
sensit
rapid
antigen
test
hcov
serolog
assay
routin
use
diagnosi
hcov
infect
due
lack
commerci
reagent
let
alon
commerci
reagent
vet
clinic
trial
regulatori
review
process
tabl
serolog
assay
hand
import
understand
epidemiolog
emerg
hcov
includ
burden
role
asymptomat
infect
particularli
import
antibodi
detect
diagnosi
case
novel
emerg
hcov
sarscov
merscov
situat
affect
patient
may
test
posit
viral
rna
particularli
earli
phase
diseas
retrospect
shown
develop
immun
respons
identifi
especi
rapid
antigen
test
andor
molecular
assay
neither
avail
stabl
serolog
use
supplementari
diagnost
tool
recent
studi
demonstr
igm
igg
antibodi
detect
day
onset
patient
infect
infect
author
recommend
use
serolog
facilit
diagnosi
infect
np
swab
specimen
collect
inappropri
molecular
assay
perform
unsatisfactorili
china
six
serolog
devic
receiv
urgent
approv
nation
medic
product
administr
nmpa
march
tabl
proper
specimen
handl
storag
import
maintain
integr
specimen
perform
serolog
test
randomamplif
deepsequenc
approach
play
critic
role
identifi
merscov
clinic
diagnost
applic
genet
heterogen
hcov
preclud
singl
panhcov
molecular
assay
tabl
pancov
assay
use
degener
primer
util
multipl
primer
set
other
employ
singl
set
nondegener
primer
current
molecular
respiratori
panel
detect
endem
hcov
requir
multipl
set
pcr
oligonucleotid
case
test
neg
endem
hcov
includ
molecular
respiratori
panel
china
time
revis
eleven
molecular
devic
shanghai
zj
biotech
shanghai
geneodx
biotech
bgi
biotech
wuhan
mgi
tech
da
gene
sansur
biotech
shanghai
biogerm
medic
biotech
capitalbio
chengdu
beij
appli
biolog
technolog
maccura
biotechnolog
wuhan
easydiagnosi
biomedicin
receiv
urgent
approv
nmpa
characterist
contrast
tabl
variabl
perform
report
devic
registr
certif
clearli
indic
certif
urgent
supplement
diagnosi
pneumonia
caus
addit
multicentr
clinic
trial
data
need
extens
one
year
among
one
mgi
tech
use
ng
techniqu
detect
pathogen
given
specimen
includ
one
innovita
use
isotherm
amplif
follow
chip
detect
nine
devic
incorpor
realtim
pcr
techniqu
hydrolysi
probe
nucleic
acid
get
extract
separ
reagent
system
extract
transfer
realtim
pcr
thermocycl
eg
abi
fast
dx
realtim
pcr
instrument
nucleic
acid
amplif
detect
sever
rtpcr
protocol
detect
rna
post
world
health
organ
http
wwwwhointemerg
laboratoryguid
access
march
three
protocol
list
us
cdc
develop
develop
rtpcr
diagnost
panel
univers
detect
sarslik
betacoronavirus
specif
detect
three
separ
rtpcr
reaction
target
n
gene
one
primerprob
set
detect
betacoronavirus
two
set
specif
assay
must
posit
report
presumpt
posit
http
wwwfdagov
access
march
specimen
type
includ
upper
lower
respiratori
specimen
np
op
swab
sputum
lower
respiratori
tract
aspir
bal
nasopharyng
washaspir
nasal
aspir
algorithm
berlin
germani
begin
two
rtpcr
assay
detect
e
rdrp
gene
subgenu
sarbecoviru
sarscov
batassoci
betacoronavirus
assay
must
posit
advanc
next
step
test
algorithm
second
step
consist
naat
monoplex
specifichcov
high
sensit
specif
special
speci
potenti
quantif
h
diagnosi
detect
differenti
limit
type
research
naat
multiplex
high
sensit
specif
cover
pathogen
filmarray
rp
ez
cliawaiv
h
diagnosi
detect
differenti
limit
type
research
naat
poct
rapid
safe
good
sensit
specif
cliawaiv
diagnosi
detect
limit
differenti
research
note
eia
enzym
immunoassay
ifa
immunofluoresc
assay
naat
nucleic
acid
amplif
test
clia
clinic
laboratori
improv
act
specif
rtpcr
target
rdrp
exclus
test
show
alphacoronavirus
betacoronavirus
merscov
detect
http
wwwwhointdocsdefaultsourc
access
februari
univers
hong
kong
li
ka
shing
faculti
medicin
protocol
use
two
assay
n
gene
screen
assay
follow
assay
confirm
detect
subgenu
sarbecoviru
sinc
sarscov
circul
human
current
case
posit
consid
infect
case
exclus
test
show
mer
yield
neg
result
http
access
februari
three
novel
coronavirus
highli
contagi
fast
safe
simpl
use
diagnost
devic
perform
near
point
care
poc
figur
shown
impact
patient
manag
control
infecti
diseas
epidem
extrem
desir
poc
biosafeti
facil
limit
tabl
sever
manufactur
spend
effort
gener
devic
poc
test
poct
id
previous
aler
influenza
b
assay
abbott
san
diego
ca
clear
us
fda
direct
use
np
swab
firstev
clinic
laboratori
improv
amend
clia
waiv
nucleic
acidbas
test
januari
similarli
xpress
flursv
cepheid
sunnyval
ca
flu
ab
rsv
roch
molecular
system
pleasanton
ca
assay
integr
nucleic
acid
extractionindepend
devic
recent
receiv
fda
clearanc
cliawaiv
simultan
detect
identif
flua
flub
rsv
nasopharyng
swab
respiratori
ez
panel
biofir
salt
lake
citi
ut
far
far
cliawaiv
syndrom
panel
cover
set
respiratori
viral
bacteri
pathogen
includ
classic
coronaviru
speci
consid
increas
level
mortal
infect
associ
three
novelcoronaviru
outbreak
randomaccess
safe
simpl
test
offer
fast
accur
detect
identif
like
immedi
impact
prompt
clinic
epidemiolog
decis
lysi
buffer
use
inactiv
infect
specimen
test
run
poc
biosafeti
cabinet
avail
fast
nearpati
poct
could
help
effici
triag
suspect
case
novel
coronaviru
help
focu
limit
resourc
enabl
appropri
use
quarantin
hand
diagnost
develop
strive
bring
fast
test
market
soon
possibl
hope
ultim
assist
ongo
outbreak
china
molecular
diagnost
test
use
develop
cepheid
hibergen
dublin
ireland
cepheid
advantag
molecular
poct
space
alreadi
instrument
place
china
mobidiag
meanwhil
may
offer
addit
benefit
multiplex
test
coronaviru
flu
virus
http
www
genomewebcompcrdiagnosticsfirmsrushdeveloprapidpointcaretestsnovelcoronaviru
access
februari
mjl
ywt
employe
cepheid
commerci
manufactur
xpert
xpress
test
figur
evolut
molecular
test
procedur
pointofcar
test
poct
devic
incorpor
nucleic
acid
extract
amplif
detect
togeth
integr
seal
cartridg
make
simpl
rapid
safe
endpoint
pcr
dna
detect
measur
complet
pcr
amplif
requir
postpcr
process
realtim
pcr
closedtub
system
dna
detect
measur
exponenti
phase
amplif
